Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 7.2B | 6.9B | 6.5B | 5.5B |
Cost of revenue | 3.0B | 2.9B | 2.8B | 1.6B |
Gross profit | 4.2B | 4.0B | 3.7B | 3.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 337.4M | 312.1M | 272.9M | 403.5M |
Operating income | 3.8B | 3.6B | 3.3B | 2.6B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 3.7B | 3.6B | 3.4B | 3.1B |
Tax provision | 912.7M | 902.7M | 846.2M | 771.3M |
Net income | 2.7B | 2.7B | 2.5B | 2.4B |
Basic EPS | 9.4 | 9.2 | 8.6 | — |
Diluted EPS | 9.4 | 9.1 | 8.5 | — |
Basic average shares | 292.6M | 292.5M | 292.5M | — |
Diluted average shares | 292.9M | 295.4M | 294.9M | — |
EBITDA | 4.0B | 3.7B | 3.4B | 3.2B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |